Víctor Asensi

5.8k total citations
128 papers, 2.3k citations indexed

About

Víctor Asensi is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Víctor Asensi has authored 128 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Infectious Diseases, 42 papers in Epidemiology and 28 papers in Virology. Recurrent topics in Víctor Asensi's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (22 papers). Víctor Asensi is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (22 papers). Víctor Asensi collaborates with scholars based in Spain, United States and Italy. Víctor Asensi's co-authors include J. A. Cartón, Julio Collazos, Eulalia Valle-Garay, Vincent Soriano, A. Hugo Montes, J. A. Maradona, Javier García‐Samaniego, Álvaro Meana, Joshua Fierer and Victoria Álvarez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Víctor Asensi

120 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Víctor Asensi 963 711 604 331 313 128 2.3k
Caterina Uberti‐Foppa 1.0k 1.1× 632 0.9× 433 0.7× 328 1.0× 146 0.5× 109 1.7k
Luís F. López‐Cortés 1.5k 1.5× 1.4k 1.9× 1.1k 1.8× 631 1.9× 316 1.0× 155 2.8k
Bruno Cacopardo 1.2k 1.3× 779 1.1× 643 1.1× 253 0.8× 224 0.7× 171 3.1k
Philip Tarr 765 0.8× 1.0k 1.4× 256 0.4× 465 1.4× 588 1.9× 110 2.9k
C. Michelet 1.1k 1.1× 1.1k 1.5× 200 0.3× 494 1.5× 175 0.6× 94 2.5k
Édouard Tuaillon 1.3k 1.4× 1.3k 1.8× 555 0.9× 547 1.7× 107 0.3× 147 2.9k
Francesco Chiodo 1.0k 1.1× 1.5k 2.0× 275 0.5× 759 2.3× 769 2.5× 215 3.1k
J Giron 768 0.8× 512 0.7× 283 0.5× 273 0.8× 79 0.3× 61 1.7k
A Vierucci 1000 1.0× 442 0.6× 656 1.1× 317 1.0× 157 0.5× 160 3.4k
Hector Bonilla 638 0.7× 1.1k 1.5× 172 0.3× 238 0.7× 180 0.6× 63 2.2k

Countries citing papers authored by Víctor Asensi

Since Specialization
Citations

This map shows the geographic impact of Víctor Asensi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Asensi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Asensi more than expected).

Fields of papers citing papers by Víctor Asensi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Asensi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Asensi. The network helps show where Víctor Asensi may publish in the future.

Co-authorship network of co-authors of Víctor Asensi

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Asensi. A scholar is included among the top collaborators of Víctor Asensi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Asensi. Víctor Asensi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izquierdo, Rebeca, Alejandro Vallejo, Inés Suárez‐García, et al.. (2025). Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 274–282.
2.
3.
Collazos, Julio, Luís Morano, Manuel Rodríguez, et al.. (2024). No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients. Scientific Reports. 14(1). 7534–7534. 2 indexed citations
4.
Montero, Estrella, et al.. (2023). Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern Spain. Parasites & Vectors. 16(1). 195–195. 10 indexed citations
5.
Charlier, Philippe, Antonio Perciaccante, Nicolas Kluger, et al.. (2023). Iconodiagnosis: Guidelines and recommendations. Ethics Medicine and Public Health. 31. 100951–100951. 10 indexed citations
6.
7.
Collazos, Julio, Peré Domingo, Antonio Lalueza, et al.. (2022). Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS ONE. 17(1). e0262777–e0262777. 5 indexed citations
8.
Montes, A. Hugo, Eulalia Valle-Garay, Julio Collazos, et al.. (2021). The TNF-α (–238 G/A) polymorphism could protect against development of severe sepsis. Innate Immunity. 27(5). 409–420. 11 indexed citations
9.
Vázquez, Esther, Yolanda M. Pacheco, Maria Jesús Pérez‐Elías, et al.. (2020). Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21. Journal of Clinical Medicine. 9(3). 760–760. 16 indexed citations
10.
Collazos, J., B De La Fuente, Javier de la Fuente, et al.. (2020). Factors associated with sepsis development in 606 Spanish adult patients with cellulitis. BMC Infectious Diseases. 20(1). 211–211. 8 indexed citations
11.
Charlier, Philippe, Simon Donell, Donatella Lippi, et al.. (2020). Hydroxy-chloroquine to treat COVID-19 – infected patients: Some lessons from medical anthropology and history of medicine. Ethics Medicine and Public Health. 15. 100587–100587.
12.
Montes, A. Hugo, J. A. Cartón, Victoria Álvarez, et al.. (2019). The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population. PLoS ONE. 14(10). e0220022–e0220022. 11 indexed citations
13.
Alejos, Belén, Inés Suárez‐García, Otilia Bisbal, et al.. (2019). Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors. PLoS ONE. 14(8). e0221598–e0221598. 5 indexed citations
14.
Collazos, Julio, Alicia García, Ian López‐Cruz, et al.. (2018). Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS ONE. 13(9). e0204036–e0204036. 17 indexed citations
15.
Collazos, J., et al.. (2018). Factors predictive of relapse in adult bacterial osteomyelitis of long bones.. BMC Infectious Diseases. 18(1). 635–635. 43 indexed citations
16.
Santos, Ignacio de los, Eulalia Valencia, Víctor Asensi, et al.. (2013). Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients. HIV Clinical Trials. 14(5). 254–261. 2 indexed citations
17.
Gómez, J.M. Fernández, et al.. (2010). Fatal Outcome Due to Sepsis by Mycobacterium Bovis Six Years After BCG Intravesical Instillations. Journal of Medical Cases. 1(3). 81–83. 2 indexed citations
18.
Asensi, Víctor, et al.. (2007). Fase no parasítica de Boophilus microplus (Acari: Ixodidae) en condiciones ambientales y de laboratorio en Costa Rica. SHILAP Revista de lepidopterología.
19.
Sánchez‐Conde, Matilde, Rosario Palacios, José Sanz, et al.. (2007). Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study. AIDS Research and Human Retroviruses. 23(10). 1237–1241. 8 indexed citations
20.
Morales, Blanca, Eliécer Coto, Víctor Asensi, Manuel Bousoño, & Julio Bobes. (2001). Polimorfismos serotoninérgicos y trastorno obsesivo-compulsivo. Psiquiatría Biológica. 8(6). 219–224. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Uberti‐Foppa Breakdown of academic impact, for papers by Luís F. López‐Cortés Breakdown of academic impact, for papers by Bruno Cacopardo Breakdown of academic impact, for papers by Philip Tarr Breakdown of academic impact, for papers by C. Michelet Breakdown of academic impact, for papers by Édouard Tuaillon Breakdown of academic impact, for papers by Francesco Chiodo Breakdown of academic impact, for papers by J Giron Breakdown of academic impact, for papers by A Vierucci Breakdown of academic impact, for papers by Hector Bonilla
Rankless by CCL
2026